FDA Hopes To Balance Upfront Time Investment With Easier Reviews In New PMA Program
This article was originally published in The Gray Sheet
Executive Summary
CDRH Director Jeffrey Shuren hopes that the early, concentrated collaboration that his staff will engage in with manufacturers for select “Expedited Access PMA” devices will make the reviews themselves substantially quicker and easier, he said in an interview.